Brothers T, Lewer D, Bonn M, Kim I, Comeau E, Figgatt M
medRxiv. 2024; .
PMID: 39398993
PMC: 11469356.
DOI: 10.1101/2024.09.20.24313898.
Morozova O, Kornilova M, Makarenko O, Antoniak S, Liulchuk M, Varetska O
J Int AIDS Soc. 2024; 27 Suppl 3:e26319.
PMID: 39030884
PMC: 11258450.
DOI: 10.1002/jia2.26319.
Latimore A, Salisbury-Afshar E, Duff N, Freiling E, Kellett B, Sullenger R
NAM Perspect. 2024; 2023.
PMID: 38784638
PMC: 11114594.
DOI: 10.31478/202309b.
Sorato M, Alemu T, Toma A, Paulos G, Mekonnen S
BMJ Open. 2024; 14(5):e083037.
PMID: 38772595
PMC: 11110607.
DOI: 10.1136/bmjopen-2023-083037.
Dellamura P, Meteliuk A, Fomenko T, Rozanova J
Front Public Health. 2024; 11:1259488.
PMID: 38239802
PMC: 10794633.
DOI: 10.3389/fpubh.2023.1259488.
A Qualitative Analysis of Barriers to Accessing HIV Prevention Services During an HIV Outbreak among Persons who Inject Drugs in West Virginia.
Hershow R, Worthington N, Adams M, McDonald R, Wilson S, McBee S
AIDS Behav. 2024; 28(2):669-681.
PMID: 38165598
PMC: 10922593.
DOI: 10.1007/s10461-023-04254-2.
Injection cessation and relapse to injection and the associated factors among people who inject drugs in Iran: The Rostam study.
Mehmandoost S, Mirzazadeh A, Karamouzian M, Khezri M, Sharafi H, Shahesmaeili A
Subst Abuse Treat Prev Policy. 2023; 18(1):72.
PMID: 38031110
PMC: 10687883.
DOI: 10.1186/s13011-023-00583-6.
Double counting of clients using services in Iran: implications for assessing the reach of harm reduction programs.
Tavakoli F, McFarland W, Ghalekhani N, Khezri M, Haghdoost A, Gouya M
Harm Reduct J. 2023; 20(1):111.
PMID: 37587473
PMC: 10429072.
DOI: 10.1186/s12954-023-00851-5.
Implementation of a Dyad-Based Intervention to Improve Antiretroviral Therapy Adherence Among HIV-Positive People Who Inject Drugs in Kazakhstan: A Randomized Trial.
Davis A, Mergenova G, Landers S, Sun Y, Rozental E, Gulyaev V
Res Soc Work Pract. 2023; 33(3):313-324.
PMID: 37576461
PMC: 10421639.
DOI: 10.1177/10497315221117543.
Feasibility and preliminary efficacy of a community support intervention for people with opioid use disorder.
Kidorf M, Peirce J, Brooner R, Yan H, Latkin C
Am J Addict. 2023; 32(6):554-562.
PMID: 37553840
PMC: 10840604.
DOI: 10.1111/ajad.13457.
Impacts of COVID-19 on sexual risk behaviors, safe injection practices, and access to HIV services among key populations in Zambia: Findings from a rapid qualitative formative assessment.
Parmley L, Nkumbula T, Chilukutu L, Chelu L, Mulemfwe C, Hanunka B
PLoS One. 2023; 18(8):e0289007.
PMID: 37527283
PMC: 10393175.
DOI: 10.1371/journal.pone.0289007.
Social and environmental determinants influencing injection drug use and HIV risk among two sister cities on the US-Mexico border: a comparative cross-sectional study, 2016-2018.
Lechuga J, Ramos R, Ludwig-Barron N, Perez G, Ramos M, Ferreira-Pinto J
Harm Reduct J. 2023; 20(1):84.
PMID: 37400843
PMC: 10318714.
DOI: 10.1186/s12954-023-00802-0.
Cognitive-behavioural treatment for amphetamine-type stimulants (ATS)-use disorders.
Harada T, Tsutomi H, Mori R, Wilson D
Campbell Syst Rev. 2023; 15(1-2):e1026.
PMID: 37131466
PMC: 8356519.
DOI: 10.1002/cl2.1026.
Using Social Media to Examine Themes Surrounding Fentanyl Misuse and Risk Indicators.
Kasson E, Filiatreau L, Kaiser N, Davet K, Taylor J, Garg S
Subst Use Misuse. 2023; 58(7):920-929.
PMID: 37021375
PMC: 10464934.
DOI: 10.1080/10826084.2023.2196574.
Injection Drug Use and Sexual Risk Behaviors Among People who Inject Drugs in Ukraine: A Random-Intercept Latent Transition Analysis.
Wiginton J, Booth R, Eaton L, Smith L, Espinosa da Silva C, Patterson T
AIDS Behav. 2023; 27(9):3012-3026.
PMID: 36929321
PMC: 10019801.
DOI: 10.1007/s10461-023-04024-0.
Methods for Assessing Spillover in Network-Based Studies of HIV/AIDS Prevention among People Who Use Drugs.
Buchanan A, Katenka N, Lee Y, Wu J, Pantavou K, Friedman S
Pathogens. 2023; 12(2).
PMID: 36839598
PMC: 9967280.
DOI: 10.3390/pathogens12020326.
Using nominal group technique to identify barriers and facilitators to preventing HIV using combination same-day pre-exposure prophylaxis and medications for opioid use disorder.
Eger W, Altice F, Lee J, Vlahov D, Khati A, Osborne S
Harm Reduct J. 2022; 19(1):120.
PMID: 36307817
PMC: 9616614.
DOI: 10.1186/s12954-022-00703-8.
Nurse Practitioner-Led Integrated Rapid Access to HIV Prevention for People Who Inject Drugs (iRaPID): Protocol for a Pilot Randomized Controlled Trial.
Khati A, Altice F, Vlahov D, Eger W, Lee J, Bohonnon T
JMIR Res Protoc. 2022; 11(10):e42585.
PMID: 36222826
PMC: 9597427.
DOI: 10.2196/42585.
The Role of Context in Integrating Buprenorphine into a Drop-In Center in Kampala, Uganda, Using the Consolidated Framework for Implementation Research.
Dickson-Gomez J, Krechel S, Katende D, Johnston B, Twaibu W, Glasman L
Int J Environ Res Public Health. 2022; 19(16).
PMID: 36012015
PMC: 9407835.
DOI: 10.3390/ijerph191610382.
The role of prevention strategies in achieving HCV elimination in Canada: what are the remaining challenges?.
Hoj S, Minoyan N, Artenie A, Grebely J, Bruneau J
Can Liver J. 2022; 1(2):4-13.
PMID: 35990720
PMC: 9202798.
DOI: 10.3138/canlivj.1.2.003.